Payment overview · 2025
General Payments
$78.55
4 reported records · 3 companies
Healthcare provider profile · identity verified
Bruce L Roach, MD
Allopathic & Osteopathic Physicians|Family Medicine · MINOT, ND · NPI 1255402301
Verified facts
What the public records show
CMS Open Payments records show Bruce L Roach, MD received $78.55 in general payments during 2025 across 4 reported records.
Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 50.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 54 claims for Synthroid by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 164 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $39.32 | 50.1% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $23.07 | 29.4% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $16.16 | 20.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $78.55 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $39.32 | 2 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $23.07 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $23.07 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $16.16 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 164 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
54 | 12 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
164 | 33 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 812 | 160 |
| Atorvastatin Calcium | Atorvastatin Calcium | 708 | 165 |
| Metformin Hcl | Metformin Hcl | 571 | 131 |
| Amlodipine Besylate | Amlodipine Besylate | 565 | 124 |
| Lisinopril | Lisinopril | 522 | 120 |
| Furosemide | Furosemide | 461 | 102 |
| Potassium Chloride | Potassium Chloride | 406 | 74 |
| Metoprolol Succinate | Metoprolol Succinate | 394 | 92 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 377 | 98 |
| Losartan Potassium | Losartan Potassium | 371 | 77 |
| Gabapentin | Gabapentin | 354 | 82 |
| Eliquis | Apixaban | 341 | 46 |
| Simvastatin | Simvastatin | 339 | 92 |
| Pantoprazole Sodium | Pantoprazole Sodium | 326 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 309 | 76 |
| Omeprazole | Omeprazole | 307 | 72 |
| Hydrochlorothiazide | Hydrochlorothiazide | 275 | 57 |
| Finasteride | Finasteride | 264 | 65 |
| Allopurinol | Allopurinol | 233 | 53 |
| Clopidogrel | Clopidogrel Bisulfate | 228 | 51 |
| Sertraline Hcl | Sertraline Hcl | 216 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 175 | 34 |
| Tramadol Hcl | Tramadol Hcl | 170 | 41 |
| Jardiance | Empagliflozin | 164 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 156 | 33 |
| Spironolactone | Spironolactone | 147 | 27 |
| Alendronate Sodium | Alendronate Sodium | 137 | 37 |
| Trazodone Hcl | Trazodone Hcl | 135 | 26 |
| Atenolol | Atenolol | 126 | 32 |
| Duloxetine Hcl | Duloxetine Hcl | 122 | 27 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 117 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 114 | 25 |
| Famotidine | Famotidine | 111 | 19 |
| Xarelto | Rivaroxaban | 111 | 19 |
| Ozempic | Semaglutide | 107 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 103 | 40 |
| Lorazepam | Lorazepam | 99 | 35 |
| Warfarin Sodium | Warfarin Sodium | 99 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 92 | 32 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 90 | 23 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 88 | 23 |
| Glipizide | Glipizide | 84 | 19 |
| Prednisone | Prednisone | 83 | 32 |
| Ezetimibe | Ezetimibe | 75 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 75 | 21 |
| Celecoxib | Celecoxib | 73 | 19 |
| Donepezil Hcl | Donepezil Hcl | 69 | suppressed |
| Glimepiride | Glimepiride | 69 | 16 |
| Digoxin | Digoxin | 68 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 67 | 14 |
| Mirtazapine | Mirtazapine | 67 | 14 |
| Memantine Hcl | Memantine Hcl | 66 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 64 | 23 |
| Doxazosin Mesylate | Doxazosin Mesylate | 62 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 61 | 18 |
| Baclofen | Baclofen | 57 | suppressed |
| Pregabalin | Pregabalin | 57 | 16 |
| Tresiba Flextouch U-100 | Insulin Degludec | 56 | 11 |
| Myrbetriq | Mirabegron | 55 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 54 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 54 | 11 |
| Montelukast Sodium | Montelukast Sodium | 54 | 13 |
| Synthroid | Levothyroxine Sodium | 54 | 12 |
| Levetiracetam | Levetiracetam | 53 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 52 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 52 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 51 | 11 |
| Meloxicam | Meloxicam | 49 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 49 | 18 |
| Trulicity | Dulaglutide | 49 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 48 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 48 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 47 | 32 |
| Citalopram Hbr | Citalopram Hydrobromide | 46 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 43 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 42 | suppressed |
| Carvedilol | Carvedilol | 41 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 41 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 40 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 40 | suppressed |
| Rybelsus | Semaglutide | 40 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 38 | suppressed |
| Gemfibrozil | Gemfibrozil | 37 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 35 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 34 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 31 | 31 |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Cephalexin | Cephalexin | 30 | 11 |
| Nitroglycerin Patch | Nitroglycerin | 30 | suppressed |
| Klor-Con M20 | Potassium Chloride | 29 | suppressed |
| Latanoprost | Latanoprost | 29 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Risperidone | Risperidone | 29 | suppressed |
| Alprazolam | Alprazolam | 28 | suppressed |
| Mounjaro | Tirzepatide | 28 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Carbamazepine | Carbamazepine | 26 | suppressed |
| Clonazepam | Clonazepam | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | 11 |
| Nitroglycerin | Nitroglycerin | 25 | 15 |
| Valsartan | Valsartan | 25 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 24 | suppressed |
| Indapamide | Indapamide | 24 | suppressed |
| Metolazone | Metolazone | 24 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 22 | 11 |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Lidocaine | Lidocaine | 21 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 21 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 21 | suppressed |
| Fluconazole | Fluconazole | 20 | 14 |
| Jantoven | Warfarin Sodium | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 18 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 18 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 16 |
| Ulticare Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Anastrozole | Anastrozole | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 16 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 16 | 12 |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Azithromycin | Azithromycin | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Entecavir | Entecavir | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
| Victoza 3-Pak | Liraglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $78.55 · 4 records | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE, QULIPTA, The Cologuard Plus Collection Kit, UBRELVY | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error